-
Spread cheer, not COVID: Tips for staying safe this holiday season
Devon Greyson, assistant professor at UBC’s school of population and public health, answers some common questions about how to stay safe and healthy this holiday season.
-
Prescribing the abortion pill without restrictions is safe and effective: UBC-led study
Abortion remains safe after Canada removed restrictions on the medical abortion pill mifepristone in November 2017.
-
Tŝilhqot’in Nation and UBC sign Memorandum of Understanding
The Tŝilhqot’in National Government (TNG) and the University of British Columbia (UBC) will be signing a memorandum of understanding (MOU) at UBC’s Vancouver campus on Wednesday.
-
UBC commits to net zero emissions by 2035
The University of British Columbia today unveiled a bold new climate action plan to accelerate emissions reductions and achieve net-zero emissions by 2035 at its Vancouver campus—15 years ahead of the previous target date.
-
‘Inclusion should trump exclusion,’ new book reminds 2SLGBTQ+ students the law is on their side
Two-Spirit, lesbian, gay, bisexual, trans, gender-diverse and queer students: the law is on your side when it comes to expressing your identity in school.
-
Review of Elephant Hill fire calls for Indigenous leadership in wildfire management and recovery
Four years after the Elephant Hill megafire burned more than 190,000 hectares and destroyed over 100 homes in B.C.’s south-central Interior region, a new Indigenous-led report is recommending fundamental changes to the way wildfire management and post-fire recovery is conducted in B.C.
-
Stem cell-based treatment produces insulin in patients with Type 1 diabetes
In the first study of its kind, a team of researchers at the University of British Columbia’s faculty of medicine and Vancouver Coastal Health (VCH) has helped to demonstrate that a stem cell-based treatment delivered through an implantable device can produce insulin in the human body.
-
Delaying second dose of mRNA COVID-19 vaccine produces stronger immune response
The first peer-reviewed study in North America examining the timing between the first and second doses of COVID-19 mRNA vaccines shows that a longer dose interval leads to a stronger immune response.
